Insider Trading activities of Par Pharmaceutical Companies, Inc. insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Par Pharmaceutical Companies, Inc. since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Par Pharmaceutical Companies, Inc. since year 2005. Table 2 shows the detailed insider transactions of Par Pharmaceutical Companies, Inc. since 2005. The reporting company's ticker symbol is PRX. The reporting company's CIK number is 878088.
The total value of stock buying since 2005 is $7,659,894.
The total value of stock sales since 2005 is $49,252,331.
The total value of stock option exercises since 2005 is $9,181,502.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Par Pharmaceutical Companies, Inc. (PRX).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2012-03 0 $0 15,000 $555,592 15,000 $431,850
2011-12 0 $0 5,000 $162,539 5,000 $149,500
2011-09 10,000 $262,360 0 $0 0 $0
2011-05 0 $0 198,860 $6,912,020 160,858 $1,958,822
2011-03 0 $0 278,432 $8,568,177 116,335 $2,438,846
2010-04 0 $0 20,000 $549,020 0 $0
2010-03 0 $0 128,291 $3,224,159 73,123 $954,985
2009-08 0 $0 302,650 $5,506,977 0 $0
2008-11 0 $0 173,500 $1,808,390 0 $0
2008-10 14,900 $157,542 0 $0 0 $0
2008-03 20,000 $345,880 0 $0 0 $0
2007-10 115,200 $2,116,917 0 $0 0 $0
2007-02 0 $0 465,000 $12,510,360 0 $0
2007-01 200 $4,820 167,047 $4,471,994 0 $0
2006-07 330,600 $4,615,176 0 $0 0 $0
2006-06 1,500 $32,250 0 $0 0 $0
2006-01 0 $0 155,535 $4,983,103 150,000 $3,247,499
2005-09 5,000 $124,949 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Par Pharmaceutical Companies, Inc. insiders (PRX)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2012-03-19 Knight Peter S (Director) Sale 7,500 37.03 277,717
2012-03-19 Knight Peter S (Director) Option Ex 7,500 28.79 215,925
2012-03-19 Nordmann Ronald M (Director) Sale 7,500 37.05 277,875
2012-03-19 Nordmann Ronald M (Director) Option Ex 7,500 28.79 215,925
2011-12-15 Knight Peter S (Director) Sale 2,500 32.52 81,287
2011-12-15 Knight Peter S (Director) Option Ex 2,500 29.90 74,750
2011-12-15 Nordmann Ronald M (Director) Sale 2,500 32.50 81,252
2011-12-15 Nordmann Ronald M (Director) Option Ex 2,500 29.90 74,750
2011-09-06 Tropiano Michael A (EVP & CFO) Buy 2,000 27.50 55,000
2011-09-06 Lepore Patrick G (Chairman, President & CEO) Buy 8,000 25.92 207,360
2011-05-10 Haughey Thomas (EVP, CAO, General Counsel) Sale 26,800 35.58 953,410
2011-05-10 Haughey Thomas (EVP, CAO, General Counsel) Option Ex 26,800 13.06 350,008
2011-05-09 Haughey Thomas (EVP, CAO, General Counsel) Sale 106,593 34.87 3,717,217
2011-05-09 Haughey Thomas (EVP, CAO, General Counsel) Option Ex 68,591 10.99 753,815
2011-05-09 Lepore Patrick G (Chairman, President & CEO) Sale 65,467 34.24 2,241,393
2011-05-09 Lepore Patrick G (Chairman, President & CEO) Option Ex 65,467 13.06 854,999
2011-03-08 Campanelli Paul (EVP, Pres-Par Pharmaceutical) Sale 52,070 30.58 1,596,758
2011-03-07 Campanelli Paul (EVP, Pres-Par Pharmaceutical) Sale 116,365 30.93 3,585,877
2011-03-07 Campanelli Paul (EVP, Pres-Par Pharmaceutical) Option Ex 116,335 20.96 2,438,846
2010-04-15 Sharoky Melvin Md (Director) Sale 20,000 27.45 549,020
2010-03-09 Macphee John A (EVP, Pres-Strativa) Sale 39,910 24.99 997,430
2010-03-03 Kenyon Lawrence A (EVP, Chief Financial Officer) Sale 21,439 25.22 540,713
2010-03-03 Kenyon Lawrence A (EVP, Chief Financial Officer) Option Ex 21,439 13.06 279,993
2010-03-02 Campanelli Paul (EVP; President - Generics) Sale 24,885 25.06 623,742
2010-03-02 Campanelli Paul (EVP; President - Generics) Option Ex 24,885 13.06 324,998
2010-03-02 Haughey Thomas (EVP, CAO, Gen Counsel) Sale 10,756 25.48 274,084
2010-03-01 Haughey Thomas (EVP, CAO, Gen Counsel) Sale 31,301 25.18 788,190
2010-03-01 Haughey Thomas (EVP, CAO, Gen Counsel) Option Ex 26,799 13.06 349,994
2009-08-25 Haughey Thomas (EVP, Chief Admin Off, Gen Cnsl) Sale 31,000 20.44 633,485
2009-08-24 Campanelli Paul (EVP, Pres. - Generics) Sale 31,234 20.28 633,425
2009-08-18 Deerfield International Ltd (Other) Sale 141,845 17.55 2,488,954
2009-08-17 Deerfield International Ltd (Other) Sale 98,571 17.76 1,751,113
2008-11-25 Deerfield International Ltd (Other) Sale 173,500 10.42 1,808,390
2008-10-17 Macphee John A (EVP, Pres Strativa Pharma) Buy 7,500 10.63 79,702
2008-10-17 Haughey Thomas (EVP and General Counsel) Buy 2,400 10.40 24,950
2008-10-17 Lepore Patrick G (Chairman, President & CEO) Buy 5,000 10.58 52,890
2008-03-05 Sharoky Melvin Md (Director) Buy 20,000 17.29 345,880
2007-10-25 Knight Peter S (Director) Buy 2,500 18.10 45,237
2007-10-05 Macphee John A (Exec VP, Pres Branded Prod Div) Buy 3,000 18.70 56,100
2007-10-03 Campanelli Paul (Exec VP, Pres-Generics Div) Buy 2,100 18.19 38,199
2007-10-03 Martino Gerard (EVP & Chief Operating Officer) Buy 5,400 18.25 98,550
2007-10-03 Haughey Thomas (Exec VP, General Counsel) Buy 2,500 18.19 45,475
2007-10-03 Smith Joseph E (Director) Buy 50,000 18.45 922,500
2007-10-03 Nordmann Ronald M (Director) Buy 2,000 18.54 37,076
2007-10-03 Lepore Patrick G (Chairman, CEO and President) Buy 30,000 18.36 550,800
2007-10-03 Abernathy John D (Director) Buy 10,000 18.25 182,470
2007-02-01 Deerfield Special Situations Fund International Lt (10% Owner) Sale 465,000 26.90 12,510,360
2007-01-31 Deerfield Special Situations Fund International Lt (10% Owner) Sale 92,505 26.52 2,453,695
2007-01-30 Deerfield Special Situations Fund International Lt (10% Owner) Sale 74,542 27.08 2,018,299
2007-01-25 Cohen Steven A/sac Capital Mgmt Lp (10% Owner) Buy 200 24.10 4,820
2006-07-18 Deerfield International Ltd (Other) Buy 330,600 13.96 4,615,176
2006-06-09 Williams Peter (Director) Buy 1,500 21.50 32,250
2006-01-31 Gutman Arie (Other) Sale 5,535 32.74 181,188
2006-01-26 Gutman Arie (Other) Sale 6,700 31.60 211,720
2006-01-26 Gutman Arie (Other) Option Ex 6,700 21.65 145,055
2006-01-25 Gutman Arie (Other) Sale 60,000 31.83 1,909,800
2006-01-25 Gutman Arie (Other) Option Ex 60,000 21.65 1,299,000
2006-01-24 Gutman Arie (Other) Sale 23,300 32.12 748,395
2006-01-24 Gutman Arie (Other) Option Ex 23,300 21.65 504,444
2006-01-23 Gutman Arie (Other) Sale 60,000 32.20 1,932,000
2006-01-23 Gutman Arie (Other) Option Ex 60,000 21.65 1,299,000
2005-09-07 Tarriff Scott L (CEO) Buy 5,000 24.99 124,949

Insider trading activities including stock purchases, stock sales, and option exercises of PRX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Par Pharmaceutical Companies, Inc. (symbol PRX, CIK number 878088) see the Securities and Exchange Commission (SEC) website.